Supraventricular TachycardiaNCT07148934
Validity and Algorithm Development for Detection of Supraventricular Tachycardia in Children-A Clinical Pilot Study
An observational study of Supraventricular Tachycardia and Atrial Fibrillation (AF), run by University of Turku at 1 site in Finland.
Trial summary
The aim of this study is to evaluate the reliability of smartphone seismocardiography (SCG) and bed-based ballistocardiography (BCG) for detecting supraventricular tachycardia (SVT) in children aged 0-10 years. The performance of these methods will be compared to the gold standard of continuous telemetry ECG recording. Read more about this study
- Who is it for?
- Ages 0 to 10 years
- Conditions the study is for
- Supraventricular Tachycardia, Atrial Fibrillation (AF)
- What is being tested?
- Smartphone seismographic recording and Bed Based Ballistocardiographic recordings
- How many people
- 60 participants
- Where
- 1 siteFinland
- Study dates
- Apr 2026to Jun 2027
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 to 10 years
- All sexes
- No healthy volunteers
- Child
Study population: N=up to 60, 30 for the study (SVT) group and 30 for the control group.
Who may be able to join
- For children in Study(SVT) group:
- received informed consent from both parents/guardians
- the child is treated in the Pediatric wards of Tyks Lighthouse hospital
- the child is between the age of 0-10 years
- the child has diagnosed or suspected SVT.
- For children in control group:
Show all 10Show fewer
- received informed consent from both parents/guardians
- the child is treated in the Pediatric wards of Tyks Lighthouse hospital
- the child is between the age of 0-10 years
- child has not diagnosed with SVT
Who cannot join
- All participant groups:
- not reaching the inclusion criteria
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Finland1 site
University of Turku
Turku, 20520
AJDAR ULLAH, (+358)404776970, ajulla@utu.fi
susanna Likitalo, susanna.m.likitalo@utu.fi
About this study
The aim of this study is to evaluate the reliability of smartphone seismocardiography (SCG) and bed-based ballistocardiography (BCG) for detecting supraventricular tachycardia (SVT) in children aged 0-10 years. The performance of these methods will be compared to the gold standard of continuous telemetry ECG recording.
Read the detailed description
This study aims to validate the use of a cardiac monitoring system, comprising a smartphone for seismocardiography (SCG) and a smart mattress for ballistocardiography (BCG), to detect supraventricular tachycardia (SVT) in children aged 0-10 years. Additionally, the study will compare heart rate and breathing rate measurements from these investigational devices against a Philips Intellivue X2 ECG Monitor, which serves as the gold standard. A convenience sample of up to 60 children (30 in the SVT group and 30 in the control group) will be recruited, and their parents will also be interviewed to explore their perceptions of arrhythmia monitoring. The primary objective is to develop and understand algorithms for differentiating SVT from sinus rhythm using SCG and BCG signals.
- Being tested
- Smartphone seismographic recording and Bed Based Ballistocardiographic recordings
- Keywords
- Supraventricular Tachycardia, Atrial Fibrillation, Seismocardiography, SmartPhone
- Medical subject headings
- Tachycardia, Supraventricular, Atrial Fibrillation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Smartphone seismographic recording and Bed Based Ballistocardiographic recordingsDiagnostic test
A short recording of heart rhythm using a smartphone and bed-based ballistocardiogram.
| Study group | Role | What they receive |
|---|---|---|
| Study( SVT) Group | Children aged 0-10 years treated in the pediatric wards of Tyks Lighthouse Hospital with diagnosed or suspected supraventricular tachycardia (SVT). Receives: Diagnostic Test: Smartphone seismographic recording and Bed Based Ballistocardiographic recordings | |
| Control Group | Children aged 0-10 years treated in the pediatric wards of Tyks Lighthouse hospital who have not been diagnosed with SVT (i.e., have a normal sinus rhythm). Receives: Diagnostic Test: Smartphone seismographic recording and Bed Based Ballistocardiographic recordings |
What is being measured
The primary outcome is the main question the study is designed to answer.
Algorithm development for Seismocardiograph and Ballistocardiograph for detecting Supraventricular tachycardia
Understanding and developing the algorithm to differentiate the supraventricular tachycardia (SVT) and sinus rhythm subjects based on seismocardiography and ballistocardiography signals.
Measured: 2025-2027
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Aug 2025
- Study startApr 2026 (estimated)
- Primary completionDec 2026 (estimated)
- Study completionJun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Supraventricular TachycardiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Turku
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Anna Axelin, University of Turku
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07148934
- Sponsor's protocol ID
- FIMEA/2025/002511-2
- Status last verified
- Apr 2026
- First submitted
- 22 Aug 2025
- Last updated
- 13 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided